These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

355 related items for PubMed ID: 16709521

  • 21. Cytomegalovirus DNAemia and disease: incidence, natural history and management in settings other than allogeneic stem cell transplantation.
    Ng AP, Worth L, Chen L, Seymour JF, Prince HM, Slavin M, Thursky K.
    Haematologica; 2005 Dec; 90(12):1672-9. PubMed ID: 16330442
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Two cases of refractory warm autoimmune hemolytic anemia treated with rituximab.
    Ramanathan S, Koutts J, Hertzberg MS.
    Am J Hematol; 2005 Feb; 78(2):123-6. PubMed ID: 15682420
    [Abstract] [Full Text] [Related]

  • 25. Experience with alemtuzumab plus rituximab in patients with relapsed and refractory lymphoid malignancies.
    Faderl S, Thomas DA, O'Brien S, Garcia-Manero G, Kantarjian HM, Giles FJ, Koller C, Ferrajoli A, Verstovsek S, Pro B, Andreeff M, Beran M, Cortes J, Wierda W, Tran N, Keating MJ.
    Blood; 2003 May 01; 101(9):3413-5. PubMed ID: 12522009
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Alemtuzumab therapy for severe autoimmune hemolysis in a patient with B-cell chronic lymphocytic leukemia.
    Lundin J, Karlsson C, Celsing F.
    Med Oncol; 2006 May 01; 23(1):137-9. PubMed ID: 16645240
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Mixed-type autoimmune haemolytic anaemia: unusual cases and a case associated with splenic T-cell angioimmunoblastic non-Hodgkin's lymphoma.
    Win N, Tiwari D, Keevil VL, Needs M, Lakhani A.
    Hematology; 2007 Apr 01; 12(2):159-62. PubMed ID: 17454198
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Current approaches for the treatment of autoimmune hemolytic anemia.
    Jaime-Pérez JC, Rodríguez-Martínez M, Gómez-de-León A, Tarín-Arzaga L, Gómez-Almaguer D.
    Arch Immunol Ther Exp (Warsz); 2013 Oct 01; 61(5):385-95. PubMed ID: 23689532
    [Abstract] [Full Text] [Related]

  • 34. Alemtuzumab as consolidation after a response to fludarabine is effective in purging residual disease in patients with chronic lymphocytic leukemia.
    Montillo M, Tedeschi A, Miqueleiz S, Veronese S, Cairoli R, Intropido L, Ricci F, Colosimo A, Scarpati B, Montagna M, Nichelatti M, Regazzi M, Morra E.
    J Clin Oncol; 2006 May 20; 24(15):2337-42. PubMed ID: 16618945
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Low-dose rituximab and alemtuzumab combination therapy for patients with steroid-refractory autoimmune cytopenias.
    Gómez-Almaguer D, Solano-Genesta M, Tarín-Arzaga L, Herrera-Garza JL, Cantú-Rodríguez OG, Gutiérrez-Aguirre CH, Jaime-Pérez JC.
    Blood; 2010 Dec 02; 116(23):4783-5. PubMed ID: 20841509
    [Abstract] [Full Text] [Related]

  • 38. Rituximab for immune cytopenia in adults: idiopathic thrombocytopenic purpura, autoimmune hemolytic anemia, and Evans syndrome.
    Shanafelt TD, Madueme HL, Wolf RC, Tefferi A.
    Mayo Clin Proc; 2003 Nov 02; 78(11):1340-6. PubMed ID: 14601692
    [Abstract] [Full Text] [Related]

  • 39. Activity of alemtuzumab in patients with CD52-positive acute leukemia.
    Tibes R, Keating MJ, Ferrajoli A, Wierda W, Ravandi F, Garcia-Manero G, O'Brien S, Cortes J, Verstovsek S, Browning ML, Faderl S.
    Cancer; 2006 Jun 15; 106(12):2645-51. PubMed ID: 16688777
    [Abstract] [Full Text] [Related]

  • 40. Alemtuzumab in solid organ transplantation and in composite tissue allotransplantation.
    Weissenbacher A, Boesmueller C, Brandacher G, Oellinger R, Pratschke J, Schneeberger S.
    Immunotherapy; 2010 Nov 15; 2(6):783-90. PubMed ID: 21091110
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.